123 related articles for article (PubMed ID: 8648834)
1. Nephrogenic adenoma of the bladder in renal transplant recipients: a report of 9 cases with assessment of deoxyribonucleic acid ploidy and long-term followup.
Fournier G; Menut P; Moal MC; Hardy E; Volant A; Mangin P
J Urol; 1996 Jul; 156(1):41-4. PubMed ID: 8648834
[TBL] [Abstract][Full Text] [Related]
2. Nephrogenic adenoma in renal transplant recipients: a truly benign lesion?
Pycha A; Mian C; Reiter WJ; Brössner C; Haitel A; Wiener H; Maier U; Marberger M
Urology; 1998 Nov; 52(5):756-61. PubMed ID: 9801094
[TBL] [Abstract][Full Text] [Related]
3. Derivation of nephrogenic adenomas from renal tubular cells in kidney-transplant recipients.
Mazal PR; Schaufler R; Altenhuber-Müller R; Haitel A; Watschinger B; Kratzik C; Krupitza G; Regele H; Meisl FT; Zechner O; Kerjaschki D; Susani M
N Engl J Med; 2002 Aug; 347(9):653-9. PubMed ID: 12200552
[TBL] [Abstract][Full Text] [Related]
4. DNA profile of nephrogenic adenoma assessed by flow cytometry.
Gaylis FD; Keer HN; Bauer KD; Kozlowski JM; Grayhack JT
Urology; 1993 Feb; 41(2):160-1. PubMed ID: 8497991
[TBL] [Abstract][Full Text] [Related]
5. Nephrogenic adenoma in renal transplant recipients.
Zeidan BS; Shabtai M; Waltzer WC; Miller F; Rapaport FT
Transplant Proc; 1992 Apr; 24(2):752-4. PubMed ID: 1566505
[No Abstract] [Full Text] [Related]
6. DNA profiles and numeric histogram classifiers in nephrogenic adenoma.
Wiener HG; Remkes GW; Birner P; Pycha A; Schatzl G; Susani M; Breitenecker G
Cancer; 2002 Apr; 96(2):117-22. PubMed ID: 11954029
[TBL] [Abstract][Full Text] [Related]
7. Nephrogenic adenoma of the bladder in renal transplant and non-renal transplant patients: a review of 22 cases.
Tse V; Khadra M; Eisinger D; Mitterdorfer A; Boulas J; Rogers J
Urology; 1997 Nov; 50(5):690-6. PubMed ID: 9372876
[TBL] [Abstract][Full Text] [Related]
8. Nuclear deoxyribonucleic acid ploidy in squamous cell bladder cancer.
Winkler HZ; Nativ O; Hosaka Y; Farrow GM; Lieber MM
J Urol; 1989 Feb; 141(2):297-302. PubMed ID: 2913348
[TBL] [Abstract][Full Text] [Related]
9. High incidence of nephrogenic adenoma of the bladder after renal transplantation.
Banyai-Falger S; Maier U; Susani M; Wiener H; Watschinger B; Hörl WH; Banyai M
Transplantation; 1998 Feb; 65(4):511-4. PubMed ID: 9500625
[TBL] [Abstract][Full Text] [Related]
10. Deoxyribonucleic acid flow cytometry in invasive bladder carcinoma: a possible predictor for successful bladder preservation following transurethral surgery and chemotherapy-radiotherapy.
Hug EB; Donnelly SM; Shipley WU; Heney NM; Kaufman DS; Preffer FI; Schwartz SM; Colvin RB; Althausen AF
J Urol; 1992 Jul; 148(1):47-51. PubMed ID: 1613879
[TBL] [Abstract][Full Text] [Related]
11. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
al-Abadi H; Nagel R
J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
[TBL] [Abstract][Full Text] [Related]
12. Nephrogenic adenoma of the urinary bladder: clinical experience and review of the literature.
Chen CS; Cheng CL
J Chin Med Assoc; 2006 Apr; 69(4):166-8. PubMed ID: 16689198
[TBL] [Abstract][Full Text] [Related]
13. Nephrogenic adenomas occurring in a patient with simultaneous kidney-pancreas transplant.
Whang M; Katz L; Ongcapin E; Geffner S; Friedman G; Mulgaonkar S; Kaplan B
Urology; 2000 Jun; 55(6):949. PubMed ID: 10840121
[TBL] [Abstract][Full Text] [Related]
14. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H
J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry: does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder.
Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
J Urol; 1993 Apr; 149(4):739-43. PubMed ID: 8455234
[TBL] [Abstract][Full Text] [Related]
16. Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladder.
Slaton JW; Dinney CP; Veltri RW; Miller CM; Liebert M; O'Dowd GJ; Grossman HB
J Urol; 1997 Sep; 158(3 Pt 1):806-11. PubMed ID: 9258087
[TBL] [Abstract][Full Text] [Related]
17. Deoxyribonucleic acid flow cytometry on primary adenocarcinoma of the bladder: an analysis of 36 cases.
Grignon DJ; el-Naggar A; Ro JY; Johnson DE; Ayala AG
J Urol; 1989 Nov; 142(5):1206-10. PubMed ID: 2810494
[TBL] [Abstract][Full Text] [Related]
18. Bladder washing flow cytometry assessment of nephrogenic adenoma of the bladder.
Kontothanassis D; Christophis J; Tamvakis N; Becopoulos T
Int Urol Nephrol; 1996; 28(4):495-7. PubMed ID: 9119634
[TBL] [Abstract][Full Text] [Related]
19. Nephrogenic adenomas as renal tubular outposts.
Ingelfinger JR
N Engl J Med; 2002 Aug; 347(9):684-6. PubMed ID: 12200558
[No Abstract] [Full Text] [Related]
20. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
Miao T; Wang Z; Sang N; Xiong R; Cao S
Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
